Safety Shot Inc (SHOT)

NASDAQ: SHOT · IEX Real-Time Price · USD
2.475
+0.105 (4.43%)
Mar 28, 2024, 10:19 AM EDT - Market open

Company Description

Safety Shot, Inc., a wellness and functional beverage company, engages in the research and development of over-the-counter products and intellectual property.

Its products pipeline includes Photocil to address psoriasis and vitiligo; JW-700 to treat hair loss; JW-500 for women's sexual wellness; NoStingz, a jellyfish sting prevention sunscreen; and JW-110 for the treatment of atopic dermatitis/eczema.

The company primarily sell its products through third-party physical retail stores and partners. The company was formerly known as Jupiter Wellness, Inc. and changed its name to Safety Shot, Inc. in September 2023.

The company was incorporated in 2018 and is headquartered in Jupiter, Florida.

Safety Shot Inc
Safety Shot logo
Country United States
Founded 2018
IPO Date Oct 30, 2020
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 10
CEO Jarrett Boon

Contact Details

Address:
1061 E. Indiantown Rd., Ste. 110
Jupiter, Florida 33477
United States
Phone 561-325-0482
Website jupiterwellness.com

Stock Details

Ticker Symbol SHOT
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
IPO Price $7.50
CIK Code 0001760903
ISIN Number US48208F1057
Employer ID 83-2455880
SIC Code 2844

Key Executives

Name Position
Brian Scott John Advisor
Jarrett Boon Chief Executive Officer and Director
Jordan Schur President and Director
Danielle De Rosa-Diaz Chief Financial Officer
Anthony Pedicelli Director of Marketing
Dr. Andy Goren M.D. Chief Medical Officer and Member of Scientific Advisory Board
David Sandler CSCS, FISSN, FNSCA, HFD, HFS, M.S., MS, RSCC Chief Manufacturing Officer
Josh Wagner Chief Revenue Officer

Latest SEC Filings

Date Type Title
Mar 20, 2024 8-K Current Report
Mar 19, 2024 8-K Current Report
Mar 18, 2024 8-K Current Report
Mar 13, 2024 8-K Current Report
Mar 13, 2024 8-K Current Report
Mar 4, 2024 8-K Current Report
Mar 1, 2024 8-K Current Report
Feb 28, 2024 8-K Current Report
Feb 27, 2024 8-K Current Report
Feb 22, 2024 8-K Current Report